CLINICAL_TRIALS trial_result · 2023-10-10

Clinical Trial Update: A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease [Phase 1]

Phase 1 trial update for LY3303560 in mild cognitive impairment or Alzheimer's disease has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-10-10